Above on, an elevated level of circulating IGF-1 and/or a lower level of IGFBP-3 was related to the increased risk of cancers, and this was supported by some studies in breast, prostate and colorectal cancers [9], [10], [11]. This evidence concerns the gene IGFBP3 and cancer.